Canonical pathways | P-value* | N of genes |
---|---|---|
NRF2-mediated Oxidative Stress Response | 1.58E-31 | 46 |
Glutathione Redox Reactions I | 1.26E-25 | 16 |
Xenobiotic Metabolism Signaling | 6.31E-22 | 44 |
Aryl Hydrocarbon Receptor Signaling | 3.98E-21 | 32 |
Mitochondrial Dysfunction | 6.31E-19 | 30 |
Glutathione-mediated Detoxification | 2.00E-18 | 15 |
Production of Nitric Oxide and Reactive Oxygen Species in Macrophages | 3.98E-16 | 31 |
Acute Phase Response Signaling | 2.51E-14 | 28 |
Antioxidant Action of Vitamin C | 1.58E-12 | 20 |
IL-8 Signaling | 1.26E-11 | 26 |
Apoptosis Signaling | 2.95E-09 | 16 |
Superpathway of Citrulline Metabolism | 4.07E-08 | 7 |
Superoxide Radicals Degradation | 1.05E-07 | 5 |
IL-6 Signaling | 1.74E-07 | 16 |
iNOS Signaling | 2.00E-07 | 10 |
VEGF Signaling | 1.29E-06 | 13 |
fMLP Signaling in Neutrophils | 1.95E-06 | 14 |
Chemokine Signaling | 3.02E-06 | 11 |
VEGF Family Ligand-Receptor Interactions | 5.50E-05 | 10 |
NF-KB Signaling | 6.31E-05 | 15 |
CCR5 Signaling in Macrophages | 1.10E-04 | 9 |
IL-17A Signaling in Airway Cells | 3.89E-04 | 8 |
Nucleotide Excision Repair Pathway | 4.07E-04 | 6 |
IL-1 Signaling | 1.10E-03 | 9 |
Nicotine Degradation II | 2.82E-03 | 6 |
Nicotine Degradation III | 7.08E-03 | 5 |
CCR3 Signaling in Eosinophils | 1.51E-02 | 8 |
eNOS Signaling | 2.63E-02 | 8 |